Advertisement

Committee Connection

 

Welcome to the ASCO Connection Forums

Please read the Forum & Comment Guidelines before proceeding.

 

Previous
 
Next
New Post
6/8/2010 9:09 PM
 
The American Society of Clinical Oncology (ASCO) issued a guideline for the use of serum markers in the diagnosis, treatment and management of germ cell tumors (GCT) in men, most commonly testicular cancer. A panel convened by ASCO conducted a systematic review of medical research literature in partnership with Cancer Care Ontario to develop the recommendations. GCTs are rare, with fewer than 9,000 new cases a year in the United States. They are also among the most curable cancers, with over 90 percent of men cured. Serum tumor markers have been routinely used for decades to help manage the care of men with GCTs, yet because such tumors are uncommon, many physicians may not be familiar with how to use them best. View the guideline and the clinical tools and resources:

http://www.asco.org/guidelines/germcelltm
 
Previous
 
Next